Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brovana vs Serevent in COPD
NCT01361984Phase 4Unknown
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by University of California, Los Angeles. Status: unknown.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01361984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01361984.